CAS 82747-56-6
:3-(4-chlorophényl)-6-méthyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol chlorhydrate (1:1)
- Cicletanine Hydrochloride
- Furo(3,4-c)pyridin-7-ol, 3-(4-chlorophenyl)-1,3-dihydro-6-methyl-, hydrochloride
Cicletanine Hydrochloride
CAS :Formule :C14H13Cl2NO2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :298.1645Cicletanine Hydrochloride
CAS :Applications A new antihypertensive agent; exhibited a natriuretic effect comparable to that of hydrochlorothiazide and furosemide within 7 h. A furopyridine derivative with antihypertensive and diuretic properties.
References Braquet, P., et al.: Lancet, 1, 1218 (1983), Guinot, P., et al.: Arzneim.-Forsch., 35, 1714 (1985), Clement, D., et al.: Int. J. Clin. Pharmacol. Res., 8, 9 (1988), Lize, J.M., et al.: Therapie, 42, 399 (1987),Formule :C14H12ClNO2·ClHCouleur et forme :Pink SolidMasse moléculaire :298.16Cicletanine hydrochloride
CAS :Cicletanine hydrochloride is a drug that has been shown to be effective in the treatment of pulmonary hypertension. It is a prodrug that is converted to cicletanine, which inhibits the activity of the cytosolic calcium-calmodulin-dependent protein kinase II (CaM kinase II). Cicletanine hydrochloride has been shown to have cardiac effects in vivo and to reduce cardiac contractility. This compound has potential side effects such as metabolic disorders, gastrointestinal problems, and fetal toxicity.
Formule :C14H13Cl2NO2Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :298.16 g/mol


